We will be at the next edition of SLAS meeting in Washington, DC February 2nd and 3th. If you wish to meet us, we will welcome you on our partner’s booth, Molecular Devices (#437)

We will talk about “Phenotypic screening in 3D culture including ECM: advantages and challenges” on Monday, February 4th between 12:30 PM and 1:15 PM (Location: 143C). In this presentation we will explain our vision of 3D culture and the importance of cellular microenvironment, our use of Molecular Devices ImageXpress® Micro Confocal system and how to use machine learning to improve 3D segmentation of biological pictures. Of course, if you have any question, contact us!

Many thanks Molecular Devices to trust in our technology and skills. We feel proud to have such a famous and loyal partner!

We will also expose our scientific poster about our innovative 3D culture technology BIOMIMESYS® hydroscaffold. We will focus on cellular differentiation and cellular functionalities in this 3D system compared to 2D cultures. The poster will be available soon in the “poster” category of our website.

SLAS 2019

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

SLAS Washington 2019: the evidence of 3D culture for drug discovery! | HCS Pharma · February 14, 2019 at 1:56 pm

[…] were really happy to participate in SLAS2019 in Washington last week. In addition to spending a few relaxing days in Washington, we enjoyed the warm welcome […]

Leave a Reply